Vantedge Medical, a portfolio company of New York-based private equity firm Aterian Investment Partners since May 2018, announced the acquisition of Hobson & Motzer, Inc. in Durham, Connecticut.
Founded in 1912, Hobson & Motzer is a manufacturer of tight tolerance consumable medical devices primarily for the global surgical stapler industry. For decades, Hobson has been partnered with leading medical device manufacturers. The company’s core capabilities include computer numerical control machining, stamping, tooling and other finishing and assembly services.
Headquartered in San Jose, California, Vantedge Medical specializes in providing manufacturing solutions to its customers operating in high-growth and dynamic end markets. Vantedge Medical has been serving its customers for more than 40 years and provides prototyping and development support, followed by complex manufacturing adhering to the highest quality standards.
Vantedge said acquiring Hobson strengthens its position as a manufacturing partner to blue-chip medical original equipment manufacturers and bolsters its consumable portfolio offering. Vantedge now operates nine facilities in the United States with more than 1,200 employees. Financial terms of the deal were not disclosed.
Weil Gotshal & Manges LLP advised Aterian on the legal aspects of this transaction.
According to data captured in the LevinPro HC database, this acquisition represents the 58th Medical Devices deal of the year. There were 113 Medical Devices acquisitions announced during 2023, and 124 announced during 2022.
